Rituximab or Rituximab biosimilar Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

University of Pennsylvania1
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1

Indications

Cancer2
Diffuse Large B-cell Lymphoma(DLBCL)1
Glioblastoma1

Other1 trial

A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma

Phase 1/2

Philadelphia, Pennsylvania1 trial

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

University of Pennsylvania

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.